Sonova Holding AG
Open
SectorGezondheidszorg
201.4 0.6
Overzicht
Wijziging aandelenprijs
24u
Min
200.2
Max
204
Inkomsten | 160M 349M |
|---|---|
Verkoop | -25M 1.8B |
K/W Sectorgemiddelde | 23.149 49.052 |
EPS | 3.16 |
Dividendrendement | 2.27 |
Winstmarge | 19.469 |
Werknemers | 18,570 |
EBITDA | 1B 1.4B |
Aanbevelingen | Neutraal |
|---|---|
12 Maanden Prognose | -0.8% downside |
Dividendrendement Sectorgemiddelde | 2.27% 2.36% |
|---|
Marktkapitalisatie | 927M 12B |
|---|---|
Vorige openingsprijs | 200.8 |
Vorige sluitingsprijs | 201.4 |
Nieuwssentiment
By Acuity
76%
24%
316 / 342 Rangschikking in Healthcare
Sonova Holding AG Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Sonova Holding AG
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.